| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473770 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders. |
| 01/06/2009 | US7473765 Cytokine zalpha11 ligand |
| 01/06/2009 | US7473763 Encoded by the full-length coding sequence of the complementary DNA deposited under ATCC accession number PTA-2591; may be fused to a heterologous polypeptide; an epitope tag or an Fc region of an immunoglobulin; diagnosis or treatment of immune related diseases |
| 01/06/2009 | US7473564 Bioassay which utilizes monoclonal antibody to determine concentration of edothelial-cell-specific molecule 1 (esm-1) in cells and detect endothelial vascular wall damage humans |
| 01/06/2009 | US7473542 Therapeutic bioactive ribonucleases for use in the tissue targeted therapy against tumors; tumor cytotoxic factors; antitumor agents |
| 01/06/2009 | US7473537 Cloned glucagon-like peptide-2 receptors |
| 01/06/2009 | US7473536 To increase the titer of avipoxviruses produced from cells after infection of cells with the avipoxvirus, wherein the host range gene is expressed in cells |
| 01/06/2009 | US7473535 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| 01/06/2009 | US7473532 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/06/2009 | US7472701 Aerosol generation device and inhalation device therewith |
| 01/06/2009 | CA2245584C Recombinant expression of s-layer proteins |
| 01/06/2009 | CA2204257C Tripeptidyl aminopeptidase |
| 01/06/2009 | CA2191407C Process for using the yeast adh ii promoter system for the biotechnological production of heterologous proteins in high yields |
| 01/06/2009 | CA2179603C Production of pharmaceutical-grade plasmid dna |
| 01/06/2009 | CA2158446C Nucleic acid coding for a tumor rejection antigen precursor |
| 01/06/2009 | CA2154628C Xylanase, microorganisms producing the same, dna molecules, process for preparing said xylanase and uses thereof |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA1341589C Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090005311 Expression vector comprising nucleotide sequences coding fructooligosaccharide (FOS)-related protein for enhancing ability of probiotic bacteria to compete in the gastrointestinal tract of mammals |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005301 207 Human Secreted Proteins |
| 01/01/2009 | US20090005299 Method For Producing Carboxy-Terminal-Amidified Peptides |
| 01/01/2009 | US20090005297 Aprotinin Variants |
| 01/01/2009 | US20090005264 Cell surface display, screening and production of proteins of interest |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004725 Gene coding for protein participating in the addition of mannose phosphate to a sugar chain of a glycoprotein originating in a yeast belonging to the genus Pichia; control of an acidic sugar chain-forming function in the core-like sugar chain of the glycoprotein contained in the yeast |
| 01/01/2009 | US20090004696 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 01/01/2009 | US20090004695 Microorganisms engineered to express both cytochrome P-450 and the ferredoxin or ferrerdoxin-like protein; hypercholesterolemia and hyperlipidemia; host cells |
| 01/01/2009 | US20090004694 Sequence of Thermotolerant L-Rhamnose Isomerase Gene and Use of the Same |
| 01/01/2009 | US20090004693 Production of Polypeptides by Improved Secretion |
| 01/01/2009 | US20090004692 Methods to enhance the activity of lignocellulose-degrading enzymes |
| 01/01/2009 | US20090004649 Vector comprising nucleotide sequences coding everninomicin; for introducing heterologous genes into actinomycete chromosome |
| 01/01/2009 | US20090004278 Enzymatically Crosslinked Protein Nanoparticles |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004212 Tumour vaccines for MUC1-positive carcinomas |
| 01/01/2009 | US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004186 Effector function enhanced recombinant antibody composition |
| 01/01/2009 | US20090004179 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/01/2009 | US20090004174 Fusion Proteins |
| 01/01/2009 | US20090004160 Mass Producing Method of Growth Factor Using Adipose Derived Adult Stem Cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004142 A cell therapy method for the treatment of tumors |
| 12/31/2008 | WO2009003178A2 Reagents and methods for cyanobacterial production of bioplastics and biomaterials |
| 12/31/2008 | WO2009002993A1 Conjugates containing hydrophilic spacer linkers |
| 12/31/2008 | WO2009001867A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 12/31/2008 | WO2009000899A1 A novel strain of bifidobacterium and active peptides against rotavirus infections |
| 12/31/2008 | WO2009000063A1 Inducible/regulated gene expression systεm in e coli |
| 12/31/2008 | WO2008135498A3 Prevention of protein degradation in mammalian cell cultures |
| 12/31/2008 | WO2008134538A3 Antibodies to human somatostatin receptor and methods of use |
| 12/31/2008 | WO2008133711A9 Random homozygous gene perturbation to enhance antibody production |
| 12/31/2008 | WO2008103751A3 Antimicrobial and anti-inflammatory therapies and compositions |
| 12/31/2008 | WO2008054945A3 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus |
| 12/31/2008 | WO2008036392A3 Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 12/31/2008 | WO2007095625A3 VOLTAGE-GATED PROTON CHANNEL, Hv1, AND USES THEREFOR |
| 12/31/2008 | WO2007087420A3 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 12/31/2008 | EP2009105A1 Novel serotype Streptococcus mutans and utilization of the same |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009101A1 Antibody modification method for purifying bispecific antibody |
| 12/31/2008 | EP2009027A1 Anti-CD40 monoclonal antibody |
| 12/31/2008 | EP2007899A2 Antibodies directed to angiopoietin-like protein 4 and uses thereof |
| 12/31/2008 | EP2007809A1 Glycosylated antibodies |
| 12/31/2008 | EP2007808A2 Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions |
| 12/31/2008 | EP2007435A2 System for targeted delivery of therapeutic agents |
| 12/31/2008 | EP1817333A4 Canine cholecystokinin 1 receptor materials and their use |
| 12/31/2008 | EP1797117A4 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 12/31/2008 | EP1718760B1 Protein phosphorylation in c-src signaling pathways |
| 12/31/2008 | EP1561820B1 Anthelmintic substance fki-1033 and process for producing the same |
| 12/31/2008 | EP1551976B1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 12/31/2008 | EP1539794B1 Benzoate- and anthranilate-inducible promoters |
| 12/31/2008 | EP1482793B1 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 12/31/2008 | EP1474507B1 Methods and materials for the production of organic products in cells of candida species |
| 12/31/2008 | EP1448760B1 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 12/31/2008 | EP1412503B1 A fusion protein |
| 12/31/2008 | EP1371732B1 Fused protein having beta 1,2-n-acetylglucosaminyltransferase ii activity and process for producing the same |
| 12/31/2008 | EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 12/31/2008 | EP1305039B1 Stable (fixed) forms of viral l1 capsid proteins, fusion proteins and uses thereof |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies |
| 12/31/2008 | EP1032672B1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 12/31/2008 | EP1028751B1 Methods and compositions comprising glycoprotein glycoforms |
| 12/31/2008 | EP0937153B1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | CN101336375A Method for detection of virulent strain of influenza type-A virus |
| 12/31/2008 | CN101336249A 新型肽化合物 Novel peptide compounds |
| 12/31/2008 | CN101336076A Method for production of soybean peptide mixture |
| 12/31/2008 | CN101334356A Gas sensors |
| 12/31/2008 | CN101333550A Method for preparing CYCLIC DIPEPTIDES compounds and use thereof |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100447150C Isolation of lectins |
| 12/31/2008 | CA2691745A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 12/30/2008 | US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 12/30/2008 | US7470775 Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins |
| 12/30/2008 | US7470774 Anti-pro1477 antibodies |